Thursday Aug 14
Six local companies with drugs in clinical trials for rare diseases
The longtime presence of companies like Genzyme, Shire and Vertex in the area has helped make Cambridge and the surrounding area a world center for rare disease drug research.
Tue Aug 12, 2014
Vertex to stop selling hepatitis C drug Incivek, once a blockbuster, in October
Vertex Pharmaceuticals has notified health care providers that it will stop selling its first blockbuster drug, Incivek, in about two months.
Thu Aug 07, 2014
Vertex's Price And Prospects Compared To Alexion
In the past, I have written fairly negative assessments on the value of Vertex .
Mon Aug 04, 2014
Net@Work Expands Sage Market Presence With Acquisition, Vertex Deal
Solution provider Net @ Work continues to expand its business within the Sage Software arena, recently acquiring another Sage reseller and striking a deal with Vertex to bring that developer's sales tax applications to the Sage market.
Nasdaq 100 Movers: CTRX, VRTX
In early trading on Monday, shares of Vertex Pharmaceuticals topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.3%.
Thu Jul 31, 2014
Vertex Receives European Approval for KALYDECOa (ivacaftor) in Eight Non-G551D Gating Mutations
Today's approval follows the positive opinion from the Committee for Medicinal Products for Human Use in June 2014.
Vertex Pharmaceuticals's Neutral Rating Reaffirmed at Zacks
's stock had its "neutral" rating restated by Zacks in a report released on Thursday.
Tue Jul 29, 2014
Vertex Reports Second Quarter 2014 Financial Results and Provides...
Vertex reported total second quarter 2014 revenues of , which adds to the company's cash balance.
Sun Jul 27, 2014
How will we pay for a $300,000 drug?
Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s.
Wed Jul 23, 2014
Chemical & Engineering News
Cystic Fibrosis Drug Combination May Be Counteracting Itself
Combination therapies are a promising strategy for correcting the most common gene mutation responsible for cystic fibrosis.
Tests suggest limitations to Vertex's cystic fibrosis treatment
Investors and patients were exuberant last month when Vertex Pharmaceuticals released results from clinical trials showing that cystic fibrosis patients' lung function improved on an experimental two-drug regimen.
Customer Interaction Solutions
Investor Alert: Class Action Lawsuit Against Vertex Pharmaceuticals...
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all purchasers of the common stock of Pharmaceuticals Incorporated between May 7, 2012 and May 29, 2012, inclusive .